CD40LG and hepatocellular carcinoma: Elevated serum SCCA-IgM levels of HCC patients have also been reported to have a relation to the decreased survival, suggesting that serum SCCA–IgM levels may make a significant contribution to the prediction of HCC therapy response [130,135].